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     Abstract—During general anesthesia, anesthesiologists who 
provide anesthetic dosage traditionally play a fundamental role to 
regulate Bispectral Index (BIS). However, in this paper, an 
optimized type-2 Self-Organizing Fuzzy Logic Controller (SOFLC) 
is designed for Target Controlled Infusion (TCI) pump related to 
propofol dosing guided by BIS, to realize automatic control of 
general anesthesia. The type-2 SOFLC combines a type-2 fuzzy 
logic controller with a self-organizing (SO) mechanism to facilitate 
online training while able to contend with operational 
uncertainties. A novel data driven Surrogate Model (SM) and 
Genetic Programming (GP) based strategy is introduced for 
optimizing the type-2 SOFLC parameters offline to handle inter-
patient variability. A pharmacological model is built for 
simulation in which different optimization strategies are tested 
and compared. Simulation results are presented to demonstrate 
the applicability of our approach and show that the proposed 
optimization strategy can achieve better control performance in 
terms of steady state error and robustness. 
 
Index Terms—anesthesia; type-2 fuzzy controller; optimization; 
surrogate model; genetic programming 
 
I. INTRODUCTION 
ENERAL anesthesia is a vital component of modern 
medicine involving medically induced unconsciousness, 
systemic analgesia, reflex inhibition and muscle relaxation. 
During the general anesthesia procedure, achieving 
unconsciousness is a potentially risky and protean process, 
which demands accurately monitoring the Depth of Anesthesia 
(DoA) and providing reasonable control of anesthetic dosage to 
maintain a safe anesthetized state for the patient.  
Electroencephalography (EEG) is the most widely used 
 
  
method clinically related to the indirect DoA monitoring [1]. 
Anesthesia delivery is traditionally controlled by experienced 
anesthesiologists manually guided by Bispectral Index (BIS), 
which can be dissected from spectral analysis of the raw EEG 
using fast Fourier techniques. Nevertheless, maintaining DoA 
is a cognitively intensive process especially during long and 
complicated multi-stage surgical procedures. Errors in infusion 
rates and dosage can impact on the patient’s post-operative 
recovery and safety.  
Automatic controllers have been applied in many 
circumstances to reduce human errors and alleviate the heavy 
burden on medical staff. Over the past two decades, the 
development of Target Controlled Infusion (TCI) pumps for 
propofol infusion based on pharmacological data of patients1 
and Computer Assisted Continuous Infusion (CACI) has 
proved its superiority to manually controlled syringe pump 
related to induction and maintenance of anesthesia [2]. The 
human body is a highly nonlinear system with high level of 
inherent uncertainties leading to challenges in achieving 
automated processes. TCI has been successfully and 
commercially applied in clinical general anesthesia. However, 
it is an open loop control system and unable to handle these 
uncertainties or adaptability to different operating conditions 
[3]. Recent researchers have focused more on closed loop 
control infusion of anesthesia [4, 5] including propofol dosing 
to regulate BIS [6, 7]. Different metabolism rates between 
patients and disturbances in the surgical environment such as 
blood loss, however, lead to considerable data loss and 
inaccuracies of traditional PID controllers. 
 Hierarchical intelligent controllers with feedback strategies 
have been implemented for dealing with these nonlinear 
biomedical systems. Here fuzzy logic controllers (FLC) provide 
a powerful methodology for handling data uncertainties [8, 9]. 
Recently, researchers have used type-2 fuzzy sets to provide 
robustness for handling short- and long-term uncertainties in 
anesthesia control [10]. Type-2 FLCs based on type-2 fuzzy 
sets have been shown to be able to handle uncertain ranges of 
parameters arising from noise and external factors affecting the 
environment [11]. This is due to type-2 fuzzy sets having 
greater design degrees of freedoms, which can handle higher 
orders of real-world uncertainties to produce potentially more 
accurate and stable control systems [12-17]. 
Nevertheless, type-2 fuzzy logic systems are not always 
able to achieve an optimal performance while coping with 
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multiple control effects such as intra- and inter-patient 
variability, pharmacokinetic and pharmacodynamic variability 
associated with biomedical processes. Firstly, the basic type of 
FLC, be it type-1 or type-2, is a fixed system and does not have 
any adaptability for handling changing operating conditions as 
the monitored patient’s response varies during surgery. 
Secondly, determining the optimum structure of the fuzzy logic 
system, the design of rule-base, type-2 fuzzy sets and scaling 
factors is challenging. This has led to recent efforts focused on 
applying adaptation mechanisms and machine learning to 
enhance FLC design. One adaptive FLC which had been 
successfully applied to anesthesia control is the Self-Organizing 
Fuzzy Logic Controller (SOFLC), which adopts a Self-
Organizing (SO) mechanism enabling online adaptation of 
FLCs [18]. The SO mechanism is a top-down, spontaneous 
system which has been developed to enhance the capability of 
FLCs to deal with dynamic changes caused by external stimuli 
or drug effects during anesthesia. Based on our previous 
research, general and Interval Type-2 (IT2) SOFLCs were 
successfully applied to anesthesia control for maintaining 
acceptable DoA [10, 19] where they were shown to outperform 
type-1 based systems. Here clinical patient data was used in 
specifying the type-2 Membership Functions (MFs) to capture 
intra and inter-patient variability. However, the fuzzy sets and 
other control parameters of the FLC could be suboptimal with 
respect to different combinations of surgical conditions and 
patient specific physiological characteristics impacting on its 
control performance. There is subsequently a need to efficiently 
optimize the parameters of the type-2 SOFLC for enhancing the 
online adaptive control of drug infusion in maintaining DoA. 
II. RELATED LITERATURE  
    Previous related research has utilized different algorithms to 
adapt and optimize the parameters of type-1 and type-2 FLCs 
for anesthesia control. Several studies have focused on 
simulating the control of drug infusion rates for regulation of 
blood pressure and muscle relaxation as part of a multivariable 
anesthesia system. In [20] a direct adaptive IT2-FLC has been 
applied where the approach uses a predefined rule-base and 
adjusts the centers of the output MFs of fired rules in response 
to deviations from the desired control response. In [21] an 
approach based on IT2 Fuzzy Neural Network (IT2FNN) 
controller is evaluated where the components of an IT2 FLC are 
defined as layers of the IT2FNN and a backpropagation 
algorithm is used to tune the centers and spreads of the input 
IT2 MFs. More recently a Genetic Algorithm (GA) is used in 
[22] to optimize the centers of the output MFs of an IT2 FLC 
for regulating DoA. These approaches, however, either 
randomly select or manually add inter and intra-variability for 
specific surgical scenarios rather than this being derived using 
real patient data. In [16] authors have applied GAs to optimise 
the parameters of type-1 and type-2 PIDs controllers for 
regulating BIS. Here patient data is used to define the parameter 
of the pharmacological anesthesia model and a GA is used to 
optimize the PID gains, scaling factors and input and output IT2 
MF parameters. Similarly, in [23] an approach using a model 
predictive controller based on an adaptive type-1 fuzzy model 
is used to regulate BIS. Patient data is again used to define a 
generic patient model in the form of fixed fuzzy control rules. 
A GA is applied online to compute the input fuzzy set 
parameters so that drug dosage can be adapted to patient 
specific characteristics [24].  
    Unlike the aforementioned techniques, SOFLC uses an 
online self-adaptive mechanism that is based on the 
modification of its fuzzy control rules. Our previous work has 
explored the use of GAs to optimize the SOFLC interval type-
2 fuzzy sets and scaling factors [25]. However, GAs involve 
running simulations for evaluating the fitness of every 
individual (candidate SOFLC) in a generated population over 
multiple generations which has proven to be a highly time-
consuming and computationally expensive process. This is due 
to the complicated iteration procedure and large control 
parameter space representing each candidate controller. 
Motivated by the desire to solve these problems, an efficient 
optimization algorithm using surrogate models (SM), have been 
developed in reference to multidisciplinary design optimization 
[26], and used to optimize the structure of fuzzy logic systems 
[27]. The algorithm adopts a response surface methodology to 
obtain an optimal response model, which significantly reduces 
the simulation time and complexity without influencing quality 
of the offspring while handling computationally expensive 
problems.  
However, differences between the patients’ physiological 
characteristics such as age, weight and height, may still result 
in unsatisfactory control performance. The optimal SM based 
solution of a single SOFLC optimization case may not be the 
optimal solution in consideration of different patient specific 
characteristics or might even be unfeasible. This is especially 
true for patients who are over or underweight, where the control 
performance tends to be unsatisfactory. Running an 
optimization process every time before the surgery for a 
specific patient is also unrealistic. Genetic Programming (GP) 
provides a methodology which can be used for automatically 
evolving interpretable symbolic regression models for 
discovering nonlinear functional relationships in data [28, 29]. 
without requiring any prior specification of the form or 
structure of the solution in advance [30]. This enables GP to 
build symbolic regression, which can simultaneously search for 
both the complex associations between predictors and outcome 
and the optimal model structure.  
    GP is therefore considered as a powerful technique for 
program configuration and has been previously applied in [31, 
32] for optimizing rules of FLCs. In our work it is used to 
alleviate the problem of requiring to run online optimization 
processes to configure the SOFLC to patient specific 
characteristics. GP evolves tree structured program which can 
be used to replace the fixed constants of SM optimized type-2 
fuzzy sets and scaling factors. The evolved programs can find 
the relationship between the patient information and parameters 
of the type-2 SOFLC to provide appropriate parameters of type-
2 fuzzy sets and scaling factors for each anesthesia case.  
    This paper proposes a holistic data-driven optimized fuzzy 
adaptive control scheme for controlling propofol dosing to 
regulate BIS as an indicator for DoA. This novel approach 
combines offline SM and GP based optimization of type-2 MFs 
and scaling factors with the online adaptation of the fuzzy 
control rules of the type-2 SOFLC. To the authors’ knowledge, 
there have been no previously conducted studies which have 
combined SM and GP for optimizing and flexibly selecting 
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parameters of adaptive type-2 FLCs applied to anesthesia 
control. The contribution of this paper is therefore: 1) the 
application of SM to optimize the input IT2 MF parameter, and 
scaling factors of type-2 SOFLCs; 2) Using GP to determine to 
best set of the optimized SOFLC parameters for patient specific 
characteristics under simulated surgical scenarios. We compare 
and evaluate the control performance of the proposed system 
with type-2 SOFLCs optimized by GA and SM as well as an 
equivalent type-1 system. 
The rest of this paper is organized as follows: in section III, 
the pharmacological model of propofol used in our simulation 
is introduced; in section IV, the IT2 SOFLC is explained; in 
section V, approaches for optimizing the type-2 SOFLCs are 
described in detail; in section VI, the experiments and results 
are presented and discussed, Finally, section VII presents 
conclusions and future works. 
III. PHARMACOLOGICAL MODEL OF PROPOFOL 
As a versatile anesthetic agent, propofol is an intravenous 
short-acting medication used for induction and maintenance of 
general anesthesia and hence widely used for computer 
controlled anesthesia [1, 6]. Moreover, BIS values ranging from 
0 to 100, are used by clinicians to interpret DoA. Awake 
patients commonly show a BIS value greater than 90. BIS 
scores between 40 and 60 are considered reasonable during 
adequate levels of general anesthesia [33]. In this paper, a non-
static anesthetic model is applied as a reference model for the 
proposed type-2 SOFLC to realize closed loop control of the 
infusion rate of propofol for regulating DoA as described in Fig. 
1. The hierarchical system consists of a type-2 FLC (a), a SO 
mechanism (b) to facilitate online tuning of the type-2 FLC 
control rules, and the combination of SM and GP to facilitate 
offline learning (c) and define the type-2 FLC system structure. 
The patient information is firstly sent to the controller to 
determine controller parameters. Then the controller predicts 
appropriate dosage for the actuator to deliver propofol based on 
the BIS set point, and the BIS error. The differential of BIS error 
is calculated and fed back to the controller after the EEG sensor 
provides a BIS score from the patient. In our surgical simulation, 
a propofol pharmacological model of the patient is applied. 
According to previous studies [34], the pharmacological model 
of propofol is usually divided into two classes to clarify the 
interaction and mechanism of the drug and the patient. The 
pharmacokinetics (PK) model is related to the rules governing 
the concentration of the drug in the body which is affected by 
the absorption, distribution, metabolism and excretion of drugs 
in the body. The pharmacodynamics (PD) model is meant to 
Fig. 2 Schematic diagram of the proposed type-2 SOFLC: (a) Self-organizing mechanism (b) Type-2 FLC (c) Offline learning  
Fig. 1 Diagram of the multivariable anesthesia system 
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study the effect of drugs on the body including drug action, 
mechanism of action and clinical application. Both models 
together represent the patient model as illustrated as a block in 
Fig. 1 and Fig. 2. The mathematical formalism of both these 
models are described in more detail in the sections below.  
A. Pharmacokinetics model 
Based on previous studies [34], the free plasma propofol 
concentration was described using  a three-compartment model: 
𝑉𝑝
𝑑𝐶𝑃
𝑑𝑡
= −(𝐶𝐿 + 𝑄1 + 𝑄2)𝐶𝑃 + 𝑄1𝐶𝑇1 + 𝑄1𝐶𝑇2 + 𝑅 
𝑉𝑇1
𝑑𝐶𝑇1
𝑑𝑡
= 𝑄1𝐶𝑃 − 𝑄1𝐶𝑇1 
𝑉𝑇2
𝑑𝐶𝑇2
𝑑𝑡
= 𝑄2𝐶𝑃 − 𝑄2𝐶𝑇2   （1） 
   where 𝐶𝑃 , 𝐶𝑇1 and 𝐶𝑇2 denote concentrations of propofol in 
the three compartments. 𝑉𝑝  , 𝑉𝑇1  and 𝑉𝑇2  denote volumes of 
distribution of the three compartments and 𝐶𝐿  denotes 
metabolic clearance of propofol. 𝑄1  and 𝑄2  denote the inter-
compartmental clearances. 𝑅 denotes the infusion rate. 
B. Pharmacodynamics model 
Based on previous studies [35], the BIS value can be 
calculated corresponded to the effect-site concentrations 
through a sigmoidal 𝐸𝑚𝑎𝑥 model: 
 𝐵𝐼𝑆(𝑡) = 𝐵𝐼𝑆0(1 − 𝐸𝑚𝑎𝑥
𝐶𝑒
𝛾
𝐸𝐶50
𝛾
+ 𝐶𝑒
𝛾) （2） 
where 𝐵𝐼𝑆0  denotes the baseline of BIS score, which is 
conventionally assigned a value of 100. 𝐸𝑚𝑎𝑥 is a constant fixed 
to 1, involving maximal effect. 𝐸𝐶50 is a constant fixed to 7.5, 
denoting the concentration for a 50% decrease in BIS score. γ 
is a constant fixed to 3, determining the steepness of the curve. 
𝐶𝑒  is a variable representing the effect compartment 
concentration parameter which can be calculated as follows: 
 
𝑑𝐶𝑒
𝑑𝑡
= 𝑘𝑒0(𝐶𝑃 − 𝐶𝑒) （3） 
where 𝑘𝑒0 represents biophase distribution rate constant fixed to 
0.456, and 𝐶𝑃  is a variable representing the central 
compartment’s concentration of propofol. 
IV. TYPE-2 SOFLC 
Our proposed type-2 SOFLC for anesthesia control consists 
of a type-2 FLC and a SO mechanism, which is a closed loop 
controller with a hierarchical structure as presented in Fig. 2. 
Both these components of type-2 SOFLC will be described in 
the sections as follows.  
A. Interval type-2 FLC 
The type-2 FLC consists of a fuzzifier, inference engine, 
rule-base, type-reducer, and a defuzzifier as proposed by J. M. 
Mendel in 1999 [36]. The type-2 FLC is characterized by a 
fuzzy MF, where the membership value (or membership grade) 
for each element of the set is itself a fuzzy set in [0, 1]. This 
allows us to capture and handle uncertainties about the degree 
of membership of an element in the fuzzy set [37]. The fuzzy 
membership grades reflect parameter variabilities observed in 
data which are captured in the Footprint of Uncertainty (FOU) 
of the type-2 fuzzy set. This gives type-2 FLC parameters more 
design degrees of freedom to represent and manage uncertain 
data driven problems. Hence, a type-2 FLC has been shown to 
perform better in handling nonlinear biomedical control 
processes such as anesthesia regulation. According to 
comparisons with different kinds of type-2 FLC, J.M. Mendel 
proposed an Interval Type-2 (IT2) FLC whose secondary MF is 
a fixed interval. IT2 FLC is considered as an efficient controller 
to solve real world problems [38] such as anesthesia control 
[10]. Several application areas have successfully applied IT2 
fuzzy sets to reduce the computational burden owing to its 
simplicity compared with general type-2 fuzzy sets. IT2 FLCs 
also provide a proven basis for introducing and evaluating 
hybrid evolutionary optimization approaches for tuning the 
fuzzy system’s parameters to enhance its performance [23, 24]. 
In this paper, we apply IT2 fuzzy sets for representing the inputs 
and output of the SOFLC following previous studies [39-41]. 
As described in Fig. 2 (b), the proposed type-2 FLC is a two-
inputs single-output system based on singleton fuzzification. 
The inputs of the type-2 FLC are the feedback error and 
differential error of BIS, which will be transformed into a 
normalized universe of discourse for use in the controller using 
input scaling factors depicted as GI in Fig. 2 (b). The fuzzy rule 
of the 2 inputs and 1 output system can be described as “IF-
THEN” rules of the form: 
IF 𝑥1is ?̃?1
𝑙 and 𝑥2 is ?̃?2
𝑙 , THEN 𝑦 is ?̃?𝑙 .         （4） 
where 𝑥1 and 𝑥2 are inputs, ?̃?  is the input fuzzy set, y is the 
output, ?̃? is output fuzzy set and l denotes the activated rule. 
 As shown in Fig. 3, seven linguistic values are used to define 
the two inputs as follows: negative big (NB), negative medium 
(NM), negative small (NS), zero (ZE), positive small (PS), 
positive medium (PM), and positive big (PB). Here, the type-2 
FOUs of the sets NB and PB are constructed based on 
parallelogram MFs extending the triangular type-1 fuzzy sets 
previously used [37, 42]. The FOU of the IT2 fuzzy set is 
bounded by both a trapezoidal Upper MF and a triangular 
Lower MF. For example, the IT2 fuzzy set ZE is constructed by 
adding a symmetric uncertainty value to a type-1 MF as Fig. 3 
shows. The uncertainty value and the dynamic flexibility of 
FOUs (as shown by the dashed lines in Fig 3) in handling 
changing and inter subject specific variabilities, can be 
Fig. 3 Interval type-2 fuzzy set employed in the proposed type-2 SOFLC 
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achieved using effective optimization schemes by combining 
SM and GP as our proposed approach illustrates in section IV. 
The inference engine uses rules activated according to input 
type-2 fuzzy sets to infer the output type-2 fuzzy sets by 
applying union operations and type-2 intersection based on t-
conorm and t-norm operations respectively, which is a 
simplified and efficient way to compute the input and 
antecedent operations of the IT2 fuzzy sets [43]. The type-
reducer then combines the output type-2 fuzzy sets to form a 
type-1 fuzzy set which is known as the type reduced set [44]. In 
this study we implement the enhanced iterative algorithm with 
stop condition method proposed by Wu et al. [45] as the type-
reducer. Four linguistic values are used to define the output 
propofol infusion rate as follows: ZE, PS, PM, and PB. The 
fuzzy sets for the outputs are simplified to intervals with center-
of-sets type-reduction method, which are based on the centroids 
of the IT2 fuzzy sets [37, 42, 43]. The simplified output fuzzy 
sets are four sub-intervals, which are the equal divisions of the 
interval [0, 1], and these remain fixed in the optimization 
process in order to reduce complexity. The controller’s crisp 
output is also transformed using the output scaling factor 
depicted as GO corresponding to the propofol infusion rate as 
shown in Fig. 2 (b). Further information on the IT2 fuzzy set 
can be found in [37, 38].  
B. Self-organizing mechanism  
As there are 7 linguistic values of the input fuzzy sets to 
define 2 input variables, the max number of possible rules is 49. 
The rule base applies a SO mechanism to facilitate online 
tuning, which means modifying the controller during its 
running process to enhance the capability and adaptability of 
FLCs to deal with dynamic changes caused by external stimuli 
or drug effects in anesthesia. The SO mechanism incorporates 
three function blocks: the previous rule-base generation, 
performance index and rule-base modification as shown in Fig. 
2 (a). 
The initial rule-base was generated from expert experience 
(i.e., anesthesiologist knowledge) as shown in Table I which 
initially has 25 rules to start with. The performance index 
evaluates the deviation from the desired response to the 
feedback from patient model and calculates the required 
changes in the output of the controller. This is based on 
assigning a reward value P to the individual control actions that 
contributed more to the present performance. The reward value 
P is generated from a fuzzy algorithm to define the desired 
performance in the form of fuzzy linguistic values, which are 
shown in Table II, derived from previous research work in [40].  
The generation and modification of the existing control rules 
will be achieved by the rule-base modification block. Given T 
is a sampling time step and n is the number of sampling steps, 
suppose at time nT, the process has a time-lag of m samples, the 
inputs of the system are e(nT) and ce(nT), the output of the 
controller is u(nT). Here e, ce, u represent error, change error 
and controller output respectively. 
For each control performance, the singleton fuzzy inputs of 
e(nT) and ce(nT) will stimulate two fuzzy subsets and help to 
define the reward value P(nT) issued by performance index 
defined in Table II. Then the control action u(nT-mT) 
contributing most to the process performance corresponding to 
e(nT-mT) and ce(nT-mT) should be u(nT- mT) + P(nT) instead 
of u(nT- mT). A fuzzy operator F{}, is applied for fuzzifying 
the parameters into linguistic value as follows: 
𝐸(𝑛𝑇 −  𝑚𝑇) =  𝐹{𝑒(𝑛𝑇 −  𝑚𝑇)} 
𝐶𝐸(𝑛𝑇 −  𝑚𝑇)  =  𝐹{𝑐𝑒(𝑛𝑇 −  𝑚𝑇)} 
𝑈(𝑛𝑇 −  𝑚𝑇)  = − 𝐹{𝑢(𝑛𝑇 −  𝑚𝑇)} 
           𝑉(𝑛𝑇 –  𝑚𝑇) = − 𝐹{𝑢(𝑛𝑇 −  𝑚𝑇) +  𝑃(𝑛𝑇)}        (5) 
then the previous implication:  
        𝐸(𝑛𝑇 −  𝑚𝑇) → 𝐶𝐸(𝑛𝑇 −  𝑚𝑇)  → 𝑈(𝑛𝑇 −  𝑚𝑇)    (6) 
will be replaced by the new one: 
        𝐸(𝑛𝑇 −  𝑚𝑇) → 𝐶𝐸(𝑛𝑇 −  𝑚𝑇) → 𝑉(𝑛𝑇 −  𝑚𝑇)    (7) 
As mentioned, P is the reward value issues by the performance 
index and E, CE, U represent linguistic error, linguistic change 
error and linguistic controller output respectively depicted in 
Table II. V is the modified rule. 
After the rule modiﬁcation procedure, a new rule will be 
generated by the method of logic examination [46] from the 
input and output data of the controller at each sampling step. If 
the new generated rule does not exist in the rule-base, it will be 
added. Otherwise, if it is already present, it will be ignored. 
Further information on the SO mechanism can be found in [47].    
V. OFFLINE TRAINING 
In this section, the SM-GP based optimization of type-2 
SOFLC through altering the width of FOU for type-2 fuzzy sets 
and adjusting the two input and output scaling factors is 
proposed. The schematic diagram in Fig. 2 (c) shows the 
interaction of combined SM and GP optimization processes and 
type-2 SOFLC. This optimization process is offline regarding 
TABLE I 
INITIAL RULE-BASE DESIGNED BASED ON ANESTHESIOLOGIST’S 
KNOWLEDGE 
Error of BIS 
Differential error of BIS 
NB NM NS ZE PS PM PB 
NB ZE  ZE  ZE  ZE 
NM  ZE  ZE  ZE  
NS ZE  ZE  ZE  PS 
ZE  ZE  PS  ZE  
PS ZE  ZE  PS  PM 
PM  PM  PM  PM  
PB PM  PM  PB  PB 
 
TABLE II 
LINGUISTIC PERFORMANCE INDEX TABLE  
Error 
Change in error 
NB NM NS ZE PS PM PB 
NB NB NB NB NM NM NS ZE 
NM NB NB NM NM NS ZE NS 
NS NB NB NS NS ZE PS PM 
ZE NB NM ZE ZE PS PM PB 
PS NM NS ZE PS PS PB PB 
PM NS ZE PS PM PM PB PB 
PB ZE PS PM PM PB PB PB 
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to the controller structure configuration. We have primarily 
used the information of 40 patients to perform the SM 
optimization to achieve the optimized parameters. GP is applied 
subsequently to find the relationship between the patient 
information and optimized parameters. The GP inspired from 
the mechanisms of natural selection and genetics for 
automatically generating programs based on stochastic search 
techniques will help define the type-2 SOFLC structure. 
A. Surrogate Model 
Surrogate modeling is an engineering method extensively 
used in the design community, and recently has been applied in 
many other areas such as computationally expensive 
experiments, function evaluations or optimization procedures 
to approximate complex simulation-based models [48]. 
Data on average height, weight and age was acquired for 40 
patients from National Taiwan University Hospital. For each 
patient, we ran SM optimization to find the optimal controller 
parameters including the FOU widths for input type-2 fuzzy 
sets and the two input and single output scaling factors. The 
objective function to be minimized here was defined as the 
steady state error from the training simulation runs of the type-
2 SOFLC. This has the effect of reducing the deviation of the 
control output from the set point and is used to produce a 
smooth control response and reduce fluctuation of BIS based on 
the propofol infusion rate. 
SM optimization commonly obeys the following steps as 
described in Fig. 2 (c). Firstly, an initial point set is randomly 
created and function evaluations are performed on the selected 
points. The method then shapes a response surface 
corresponding to the data generated and uses it to predict the 
fitness of the objective function at unsampled points within the 
variable domain. This process helps to select points to perform 
the next evaluation. The approach continually keeps performing 
the evaluation on the set of selected points and uses the fittest 
point set to update the model until the stopping criterion has 
been met. Typically, the stopping criteria is a maximum number 
of allowed function evaluations, which we define as 200. 
We chose a mixture of cubic radial basis function interpolant 
and kriging model with Gaussian correlation function for 
specifying the response surface. Candidate Point Sampling 
Strategy (CAND) is used as the sampling strategy and the 
Symmetric Latin Hypercube Sampling Strategy (SLHD) is used 
as the experimental design strategy. In addition, we deﬁne the 
number of points in the initial experimental design to be 10, 
which has been shown to performs well in 4-dimensional 
problems [48].   
B. Genetic Programming 
GP is a branch of evolutionary artificial intelligence 
introducing the methodologies of Automatically Defined 
Functions (ADF), which relevels specific abilities to develop 
relationships between specific system inputs and outputs and 
has been applied in several areas [49]. GP based regression can 
produce relatively simple predictive models through the 
evolutionary discovery and optimization of unknown 
coefficients for determining nonlinear system input/output 
relationship [29]. Unlike other machine learning techniques 
such as Artificial Neural Networks and Support Vector 
Machines. GP can simultaneously determine interpretable 
expressions to explain this functional relationship [29, 50, 51] 
and achieve reasonable generalizing behavior as compared to 
other approaches. As the patient characteristics impact on the 
pharmacokinetics and pharmacodynamics model of propofol, 
GP is an efficient method to find the relationship between 
patient information and effects of different parameter settings. 
GP develops its structure in the adaptive evolution of 
programs where individuals are usually expressed as syntax 
trees rather than strings (as is the case with GAs). As described 
in Fig. 2 (c), during the GP running process, the initial 
population is generated randomly. Typically, the structures of 
individuals are configured with the aid of branches. GP 
implements the following genetic operators: Fitness Evaluation, 
Selection, Crossover and Mutation. Individuals are selected 
through these genetic operators for producing the next 
generation of offspring. The process of measuring fitness is to 
sum the absolute error. GP continues generating new population 
and performing fitness evaluation until a stopping criteria is met. 
The implementation of these operators makes GP significantly 
different from other evolutionary algorithms [30]. In Fig. 4, 
examples of crossover and mutation operations are shown. The 
subtree crossover operator randomly selects a crossover point 
and creates new offspring by exchanging the branches rooted 
with the parent trees. The subtree mutation operator selects a 
mutation point and replaces the branches rooted with a 
randomly generated subtree [30]. Simplification and 
encapsulation are two other secondary operators to simplify the 
redundant symbols of complex trees and encapsulate the most 
frequent subtree into a user-defined function. The population 
size, generation and reproduction rate in our work are defined 
as 1000, 100 and 0.1 respectively. The possibility of crossover 
and mutation to generate new individuals is defined as 0.5 and 
0.3 respectively. Tournament selection is applied for generating 
a mating pool, which is robust in noisy environments. 
    To apply GP, we used the data on the height, weight and age 
acquired from the 40 patients to perform patient specific SM 
optimizations of the type-2 SOFLC parameters. This resulted in 
4 datasets corresponding to FOU for input type-2 fuzzy sets, 
two input scaling factors and one output scaling factor, which 
are defined as the output of GP. We define the input set of the 
Fig. 4 Diagrams of (a) subtree crossover and (b) subtree mutation  
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GP to be the weights of the 40 patients as weight is the most 
significant factor observed to impact anesthesia regulation. The 
GP can then be used to build regression models, which will 
replace the 4 fixed parameters of the initial type-2 SOFLC. 
Based on the optimization results of SM, a tree structured 
program formed by the GP will help the SOFLC directly build 
its best structure for a specific patient according to the patient 
weight input to the TCI. There are four GP trees to optimize the 
structure of the IT2 SOFLC corresponding to the FOU width 
for input type-2 fuzzy sets, two input scaling factors and one 
output scaling factor respectively. Fig. 5 is an example of the 
GP tree to define the FOUs for input type-2 fuzzy sets with 
regards to a patient’s weight. The internal nodes of the tree 
correspond to function set (F), the variables and constants 
correspond to terminal set (T). The maximal layer of the GP 
tree is defined as 17.  Using this approach, the FOU of type-2 
fuzzy sets becomes flexible to patient specific characteristics as 
described in Fig. 3. Furthermore, the input and output scaling 
factors are programs rather than fixed constants which enables 
the type-2 SOFLC to handle the uncertainties of inter-patient 
variabilities.  
VI. SIMULATIONS AND RESULTS 
In this section, our proposed type-2 SM-GP SOFLC is 
evaluated against variant optimization strategies for tuning the 
type-2 SOFLC parameters. We also compared our approach 
with an equivalent type-1 SOFLC based optimized system. To 
provide a robust comparative evaluation our approach was 
compared against a GA and SM only optimized SOFLC to 
evaluate its performance in surgical control simulations. 
Clinical data on patient cha racteristics which include age, 
height and weight were acquired for 20 patients from National 
Taiwan University Hospital. These patient parameters were 
different from those used for optimizing the SOFLCs as 
described in section IV. Each type of optimized IT2 SOFLC 
was applied to these 20 patients’ characteristics to evaluate their 
simulated optimization capability and performance. During the 
simulation, the weight, height and age of the 20 patients were 
used to calculate metabolic clearance and inter-compartmental 
clearances which influence propofol concentration in the 
human body and further leads to differences in BIS output 
(response).  
GA optimization was applied to both type-1 and type-2 
SOFLC. For GA settings, real numbers were adopted for 
encoding each individual chromosome. The crossover operator 
used was a Laplace crossover based on Laplace distribution; the 
mutation operator was power mutation based on power 
distribution; and the selection technique was tournament 
selection. Individuals were selected using the genetic crossover 
and mutation operators for producing the next generation. The 
maximum number of generations was defined as 200. A 
population size of 50 was used in order to make the GA more 
efficient to process more solutions at the same time without 
increasing the iteration time. Based on the length of 
chromosome and accuracy requirement, we specified the 
probability of crossover to be 0.9 and the probability of 
mutation to be 0.1 to guarantee biodiversity of solutions and 
avoid the effect of instability or premature convergence.  
At the beginning of the surgery, the TCI pump initially 
provided a bolus to make the patient fall asleep quickly, causing 
a quick drop of BIS value. The proposed controller began to 
work after 10 minutes. The entire surgical simulations of 100 
minutes were performed emulating realistic surgery durations, 
during which anesthesia is continually administered and 
regulated in a patient. In practical clinical settings, EEG 
readings can be easily influenced by signal noise which make it 
difficult to produce very precise control. Hence, we simulate 
the addition of white noise at 5%, 10% and 20% between 25 to 
30 minutes, 55 to 60 minutes and 85 to 90 minutes of drug 
administration. Clinically, a BIS value between 40 and 60 is 
recommended in general anesthesia [33, 52]. In our simulations, 
the BIS set point was 40 and the duration was 100 minutes 
representing a realistic timescale for an ear, nose and throat 
surgical procedure. The steady state error and total propofol 
dosage were calculated from 10 minutes into each simulation 
and run up to the end of the simulation. At the same time, the 
points where the BIS value dipped to 30 were also recorded. 
This is of vital importance to assess safe anesthesia as BIS 
values of less than 30 will lead to burst suppression which can 
be dangerous for patients. Fig. 6-9 show the simulation results 
for each of the 20 patients to provide a detailed and 
comprehensive comparison between the different SOFLC 
optimization strategies applied. Table III shows the average 
value and standard deviation of steady state error, total dosage 
and frequency of BIS reaching 30 for the 20 patients sampled.  
From Fig. 6 and Fig. 7, it can be concluded that the optimized 
type-1 SOFLC produce significantly higher errors than the 
type-2 SOFLC. Some of the simulation results of the type-1 
SOFLC failed to reach the set point, which also suggests it is 
poorly adapting to inter-patient and intra-patient variabilities. 
The average 𝑀𝐴𝐸𝐵𝐼𝑆 and 𝑆𝑡𝑑𝑣𝐵𝐼𝑆 of type-2 SOFLCs are also 
significantly lower compared with type-1 SOFLC. From Fig. 7 
and Fig. 8, it can be observed that SM optimized type-2 SOFLC 
has less control oscillations than the GA optimized type-2 
SOFLC and settles closer to the set point of BIS. This 
performance is shown to be further enhanced with the SM-
based GP optimized SOFLC as observed from Fig. 8 and Fig. 
9. The GP optimized type-2 SOFLC reveals greater robustness 
while handing inter-patient variability since there are only 2 
patients whose average 𝑀𝐴𝐸𝐵𝐼𝑆 are larger than 2 compared to 
 Fig. 5 An example of GP tree 
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7 and 5 for the GA and SM respectively. Moreover, one can 
notice that the average 𝑀𝐴𝐸𝐵𝐼𝑆 and 𝑆𝑡𝑑𝑣𝐵𝐼𝑆 produced by SM-
based GP optimized SOFLC is 1.4012 and 1.8102, which is 
significantly lower compared with the SOFLC in previous 
studies [10, 25]. The average frequency of BIS falling to below 
30 for the GP optimized SOFLC is 0.8, whereas they are 18.7 
and 1.9 for GA and SM optimized SOFLCs respectively. Every 
time BIS values falls below 30 in the simulation means that the 
BIS score falls below 30 for 0.01 second in the real clinical 
procedure. For the proposed GP optimized type-2 SOFLC, as 
the average frequency of BIS falling to below 30 is 0.8, the 
average actual time duration for BIS dropping below 30 is 
0.008s throughout the simulation, which is extremely short and 
considered within acceptable boundaries. The results above 
show that the SM-based GP optimized SOFLC performs well 
in dealing with different surgical problems.  
A statistical comparison of the controllers was also performed 
using the Wilcoxon sign-rank tests where significant difference 
in performance are show as p values of < 0.05. The results show 
that the p value between the  𝑀𝐴𝐸𝐵𝐼𝑆 of SM and SM-based GP 
type-2 systems is 0.002, proving that the GP combined 
optimized type-2-SOFLC significantly differs from type-2 
SOFLC optimized by SM alone.  
Fig. 6 GA optimized type-1 SOFLC applied to 20 patients   
Fig. 8 SM optimized type-2 SOFLC applied to 20 patients 
 
Fig. 9 SM-based GP optimized type-2 SOFLC applied to 20 patients 
Fig. 7 GA optimized type-2 SOFLC applied to 20 patients 
TABLE III  
THE SIMULATION RESULTS APPLIED TO 20 PATIENTS BY OPTIMIZED SOFLC 
Results 
GA optimized type-1 SOFLC GA optimized type-2 SOFLC 
𝑴𝑨𝑬𝑩𝑰𝑺 𝑺𝑼𝑴𝒑𝒓𝒐𝒑  𝑺𝒕𝒅𝒗𝑩𝑰𝑺 BIS<30 𝑴𝑨𝑬𝑩𝑰𝑺 𝑺𝑼𝑴𝒑𝒓𝒐𝒑  𝑺𝒕𝒅𝒗𝑩𝑰𝑺 BIS<30 
Avg 10.9799 1853.2957 5.6885 102.9 1.8527 1874.6966 2.3154 18.65 
Stdv 8.0243 2.7963 0.3594 -- 0.3301 11.8920 0.3694 -- 
Results 
SM optimized type-2 SOFLC SM-based GP optimized type-2 SOFLC 
𝑴𝑨𝑬𝑩𝑰𝑺 𝑺𝑼𝑴𝒑𝒓𝒐𝒑  𝑺𝒕𝒅𝒗𝑩𝑰𝑺 BIS<30 𝑴𝑨𝑬𝑩𝑰𝑺 𝑺𝑼𝑴𝒑𝒓𝒐𝒑  𝑺𝒕𝒅𝒗𝑩𝑰𝑺 BIS<30 
Avg 1.7891 1828.8150 1.9996 1.90 1.4012 1845.5976 1.8108 0.80 
Stdv 0.2976 10.9564 0.4220 -- 0.3881 17.6070 0.2641 -- 
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    The proposed GP optimized type-2 SOFLC is more robust, 
approximates and more stably maintains the control set point 
for maintaining BIS in comparison with other accepted 
approaches for anesthesia control such as the model adaptive 
controller (MAC) [7, 53] and a linear model predicative 
controller (LMPC) [54]. In comparison with the general 
(zSlices) based type-2 SOFLC whose fuzzy sets were defined 
using data acquired from monitoring physiological parameters 
of anesthetized patients [10], the optimized interval type-2 
SOFLC controller potentially has less processing overheads. 
The approach however has greater structural flexibility to 
handle inter-patient variabilities than non-optimized IT2 
SOFLCs.   
VII. CONCLUSION 
In this paper, different optimization strategies are tested and 
compared with the simulation of 20 patients, and a novel 
interval type-2 SOFLC optimized by the combination of SM 
and GP is proposed. Since the width of FOU, input and output 
scaling factors are programs rather than constants, this 
alternative strategy for the optimization of type-2 SOFLC has 
been shown to be effective in producing improved robustness 
under different circumstance with varying noise based on a 
comparison with GA optimized type-2 and type-1 SOFLC to 
regulate BIS during general anesthesia. The inter-patient 
variability is also shown to be handled well by the proposed 
optimization strategy. 
A limitation of our proposed GP optimization strategy is that 
it is time-consuming if more parameters are included in the 
optimization domain since it is a single input and single output 
regression system. Hence there is a need for four GP trees for 
each of the four system parameters respectively. So, the GP 
optimization process needs to run four times to build each GP 
tree. General type-2 fuzzy sets can be considered in the future 
as they provide higher design dimensions for modeling 
uncertainties. However, the increased numbers of parameters in 
the MF will lead to a more complicated solution space for the 
GP resulting in a more time consuming training process.  
This problem can however be solved if we adopt Cartesian 
Genetic Programming (CGP) [55], which is a multi-input and 
multi-output optimization algorithm representing 
computational structures as a string of integers. Applying CGP, 
the optimization strategy can more efficiently involve multiple 
parameters as the GP optimization process only needs to be run 
once for all system parameters. More patient information 
including age and height can be used to define the controller 
structure as compared to currently only considering the weight 
of patient to generate type-2 fuzzy sets and scaling factors. 
Furthermore, parameters inside the SO mechanism can be 
included in the optimization procedure using the multi-input 
and multi-output algorithm which might be a solution for 
reducing oscillation of SOFLC. 
Future work will investigate the use of more patient 
information and SOFLC parameters represented using general 
type-2 fuzzy sets that could be optimized using a CGP.  
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